Breakthrough in Malaria Research: Human Antibodies Offer New Hope

**Malaria remains a significant global health threat**, particularly impacting young children in Africa, causing over 600,000 deaths annually. Recent research published in *Nature* describes a promising breakthrough involving human antibodies that target proteins causing severe malaria, particularly those from the Plasmodium falciparum parasite. This parasite modifies red blood cells, leading to impaired blood flow and complications like cerebral malaria, largely due to proteins called PfEMP1. These proteins bind to the EPCR receptor, causing vessel damage. The study reveals two human antibodies targeting a section of PfEMP1, known for its role in EPCR binding. While most animal models were unsuitable due to species-specific protein differences, researchers used *organ-on-a-chip* technology to mimic human blood vessels and demonstrated that these antibodies effectively prevent cell accumulation. This finding highlights a potential pathway for vaccines or treatments for severe malaria. Led by international experts, including Maria Bernabeu and Viola Introini, the research underscores the importance of interdisciplinary collaborations in addressing complex diseases like malaria.